BHST

BioHarvest Sciences Inc. (BHST) Business Model Analysis (2026)

Invetso Score: 6.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Value Proposition Revenue Model

Score: 6.4 (Moderate)

Recurring software-led revenue mix: R&D intensity of 16.3% of revenue indicates a product-led model that can support recurring demand, but it is not enough alone to imply premium monetization.

Capital-light delivery structure: Capex at 6.3% of revenue suggests the company can deliver growth without heavy fixed-asset investment, supporting margin flexibility versus asset-heavy peers.

Moderate asset productivity: Asset turnover of 0.80x implies reasonable revenue generation from the asset base, but it remains below the efficiency typically seen in top-tier software models.

Cost Structure

Score:

Low stock-based compensation burden: Stock-based compensation at 0.4% of revenue limits dilution-related cost pressure and supports cleaner operating economics versus equity-heavy peers.

Meaningful development spend: R&D at 16.3% of revenue creates a persistent cost base that can pressure near-term margins, even if it supports product renewal and feature depth.

Limited capital expenditure drag: Capex at 6.3% of revenue keeps reinvestment needs manageable, improving cost flexibility relative to businesses with heavier infrastructure requirements.

Scalability Operating Leverage

Score:

Software-like reinvestment profile: High R&D and low capex indicate a scalable model, but the available metrics do not show the operating leverage of the strongest subscription peers.

Asset-light expansion potential: Low capital intensity can support incremental revenue growth without proportional fixed-cost growth, improving scalability if demand remains steady.

Efficiency still mid-tier: Asset turnover below 1.0x suggests the model is scalable, but current productivity is not yet at the level of the most efficient peer set.

Customer Structure Concentration

Score:

Customer concentration not disclosed in provided metrics: The supplied data does not show customer concentration, limiting visibility into whether revenue is diversified or exposed to a small number of accounts.

Model likely depends on product adoption breadth: A development-heavy, capital-light structure typically requires broad customer adoption to scale efficiently, which can temper predictability if concentration is high.

Revenue Quality Predictability

Score:

Income quality supports earnings conversion: Income quality of 0.79x suggests reported earnings convert reasonably into cash, supporting revenue quality versus peers with weaker accrual profiles.

Cash flow visibility remains incomplete: FCF margin is unavailable in the provided data, so predictability cannot be assessed as strongly as for peers with clearer free-cash-flow disclosure.

R&D-led model can improve durability: Sustained product investment can support renewal and retention, but it also creates ongoing dependence on continued innovation to preserve revenue quality.

Overall Score

Score:

BHST appears to have a capital-light, software-like business model with reasonable efficiency, but its structural profile remains mid-tier because operating leverage and revenue visibility are not clearly exceptional.

Score Driver: The Dominant Positive Driver Is Low Capital Intensity, While The Main Limitation Is Only Moderate Asset Productivity And Incomplete Visibility Into Customer Concentration And Cash-Flow Durability.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on BioHarvest Sciences Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →